BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31306487)

  • 1. Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.
    Jarkvist J; Salehi C; Akin C; Gülen T
    Allergy; 2020 Jan; 75(1):169-177. PubMed ID: 31306487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM; Durham SR
    Front Immunol; 2019; 10():1959. PubMed ID: 31497015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal
    Rijavec M; Inkret J; Bidovec-Stojković U; Carli T; Frelih N; Kukec A; Korošec P; Košnik M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003556
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
    Bonadonna P; Gonzalez-de-Olano D; Zanotti R; Riccio A; De Ferrari L; Lombardo C; Rogkakou A; Escribano L; Alvarez-Twose I; Matito A; Vega A; Passalacqua G
    J Allergy Clin Immunol Pract; 2013; 1(5):474-8. PubMed ID: 24565619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal anaphylactic sting reaction in a patient with mastocytosis.
    Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
    Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
    Bonadonna P; Scaffidi L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):455-468. PubMed ID: 30007463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study.
    Poli F; Longo G; Parmiani S
    Allergol Immunopathol (Madr); 2001; 29(5):191-6. PubMed ID: 11720652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of hymenoptera venom allergy and venom immunotherapy.
    Bilò MB; Tontini C; Martini M; Corsi A; Agolini S; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2019 Nov; 51(6):244-258. PubMed ID: 31594296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.